Expert Opinion on Pharmacotherapy, Volume 18, Issue 1 (2017)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Pharmacotherapy, Volume 18, Issue 1 (2017)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Volume 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
Pharmacotherapy for obsessive-compulsive disorder (OCD): predicting response and moving beyond serotonin re-uptake inhibitors
Vlasios Brakoulias & Emmanouil Tsalamanios
Pages: 1-3
Published online: 28 Oct 2016
First Page PreviewforPharmacotherapy for obsessive-compulsive disorder (OCD): predicting response and moving beyond serotonin re-uptake inhibitors | Full Text | References | PDF (295.5 KB)
  • 2200 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
Attitudes of patients and physicians to insulin therapy in Japan: an analysis of the Global Attitude of Patients and Physicians in Insulin Therapy study
Shin-ichi Harashima, Akiko Nishimura & Nobuya Inagaki
Pages: 5-11
Published online: 05 Dec 2016
AbstractforAttitudes of patients and physicians to insulin therapy in Japan: an analysis of the Global Attitude of Patients and Physicians in Insulin Therapy study | Full Text | References | PDF (611.1 KB) | Supplemental
  • 2676 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access
Article
Effect of 24-week treatment with ipragliflozin on proinsulin/C-peptide ratio in Japanese patients with type 2 diabetes
Yoshio Nagai, Akio Ohta, Yukiyoshi Sada, Hiroyuki Kato & Yasushi Tanaka
Pages: 13-17
Published online: 21 Nov 2016
AbstractforEffect of 24-week treatment with ipragliflozin on proinsulin/C-peptide ratio in Japanese patients with type 2 diabetes | Full Text | References | PDF (716.1 KB)
  • 845 Views
  • 8 CrossRef citations
  • 0Altmetric

Review

Review
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer
Carlo Genova, Erika Rijavec, Federica Biello, Giovanni Rossi, Giulia Barletta, Maria Giovanna Dal Bello, Irene Vanni, Simona Coco, Angela Alama & Francesco Grossi
Pages: 19-33
Published online: 23 Nov 2016
AbstractforNew systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer | Full Text | References | PDF (1.3 MB)
  • 367 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
New chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails?
Hyun Young Woo, So Young Yoo & Jeong Heo
Pages: 35-44
Published online: 28 Nov 2016
AbstractforNew chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails? | Full Text | References | PDF (1 MB)
  • 914 Views
  • 15 CrossRef citations
  • 0Altmetric
Review
Can new chemical therapies improve the management of multiple sclerosis in children?
Emanuele D’Amico, Aurora Zanghì & Francesco Patti
Pages: 45-55
Published online: 16 Dec 2016
AbstractforCan new chemical therapies improve the management of multiple sclerosis in children? | Full Text | References | PDF (1.2 MB)
  • 219 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Second line small molecule therapy options for treating chronic myeloid leukemia
Matteo Molica, Fulvio Massaro & Massimo Breccia
Pages: 57-65
Published online: 09 Dec 2016
AbstractforSecond line small molecule therapy options for treating chronic myeloid leukemia | Full Text | References | PDF (684.2 KB)
  • 625 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation
Francisco Marín, Manuel Anguita-Sánchez & Marcelo Sanmartín
Pages: 67-77
Published online: 15 Dec 2016
AbstractforDirect oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation | Full Text | References | PDF (974.7 KB)
  • 616 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Pharmacological management of pulmonary embolism
Bobby Gouin, Helia Robert-Ebadi, Marc Righini & Marc Blondon
Pages: 79-93
Published online: 20 Dec 2016
AbstractforPharmacological management of pulmonary embolism | Full Text | References | PDF (1.1 MB)
  • 809 Views
  • 3 CrossRef citations
  • 0Altmetric
Review
Advances in chemical pharmacotherapy to manage advanced breast cancer
Andrea Gombos & Ahmad Awada
Pages: 95-103
Published online: 16 Dec 2016
AbstractforAdvances in chemical pharmacotherapy to manage advanced breast cancer | Full Text | References | PDF (688.3 KB)
  • 288 Views
  • 3 CrossRef citations
  • 0Altmetric

Drug Evaluation

Article
Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer
M. Raschid Hoda, Mario W. Kramer, Axel S. Merseburger & Marcus V. Cronauer
Pages: 105-113
Published online: 28 Nov 2016
AbstractforAndrogen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer | Full Text | References | PDF (879.9 KB)
  • 772 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profile
Carle Paul, Bo Bang & Mark Lebwohl
Pages: 115-121
Published online: 20 Dec 2016
AbstractforFixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profile | Full Text | References | PDF (939.2 KB)
  • 536 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease
Tushar Sharma, Kevin Bliden, Rahul Chaudhary, Udaya Tantry & Paul A. Gurbel
Pages: 123-131
Published online: 20 Dec 2016
AbstractforEfficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease | Full Text | References | PDF (851.8 KB)
  • 405 Views
  • 6 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Advances in the pharmacological management of bronchopulmonary dysplasia: an update of the literature
Tolu Oluwole-Ojo et al.
Review Article | Published online: 23 Jul 2024
Clinical challenges and considerations in pharmacotherapy of osteoporosis due to menopause
Santiago Palacios et al.
Review Article | Published online: 23 Jul 2024
A spotlight on using HIF-PH inhibitors in renal anemia
Motoki Odawara et al.
Report | Published online: 17 Jul 2024
Considerations when treating influenza infections with oseltamivir
Chunping Gu et al.
Review Article | Published online: 15 Jul 2024
View all latest articles